DE69222444D1 - Substituierte 1,2,3,4-Tetrahydrocyclopent[b]indole, 1,2,3,3a,4,8a-Hexahydrocyclopent[b]indole und verwandte Verbindungen, Zwischenprodukte und ein Verfahren zur Herstellung derselben und ihre Verwendung als Medikamente - Google Patents

Substituierte 1,2,3,4-Tetrahydrocyclopent[b]indole, 1,2,3,3a,4,8a-Hexahydrocyclopent[b]indole und verwandte Verbindungen, Zwischenprodukte und ein Verfahren zur Herstellung derselben und ihre Verwendung als Medikamente

Info

Publication number
DE69222444D1
DE69222444D1 DE69222444T DE69222444T DE69222444D1 DE 69222444 D1 DE69222444 D1 DE 69222444D1 DE 69222444 T DE69222444 T DE 69222444T DE 69222444 T DE69222444 T DE 69222444T DE 69222444 D1 DE69222444 D1 DE 69222444D1
Authority
DE
Germany
Prior art keywords
indoles
intermediates
preparation
hexahydrocyclopent
tetrahydrocyclopent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69222444T
Other languages
English (en)
Other versions
DE69222444T2 (de
Inventor
Helen Hu Ong
Gerard Joseph O'malley
Michael Clayton Merriman
Mark Gabriel Palermo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Publication of DE69222444D1 publication Critical patent/DE69222444D1/de
Application granted granted Critical
Publication of DE69222444T2 publication Critical patent/DE69222444T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DE69222444T 1991-01-18 1992-01-18 Substituierte 1,2,3,4-Tetrahydrocyclopent[b]indole, 1,2,3,3a,4,8a-Hexahydrocyclopent[b]indole und verwandte Verbindungen, Zwischenprodukte und ein Verfahren zur Herstellung derselben und ihre Verwendung als Medikamente Expired - Lifetime DE69222444T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/642,952 US5100891A (en) 1991-01-18 1991-01-18 Substituted 1,2,3,4-tetrahydrocyclopent[b]indoles, 1,2,3,3a,4,8a-hexahydrocyclopent[B]indoles and related compounds

Publications (2)

Publication Number Publication Date
DE69222444D1 true DE69222444D1 (de) 1997-11-06
DE69222444T2 DE69222444T2 (de) 1998-06-04

Family

ID=24578739

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69222444T Expired - Lifetime DE69222444T2 (de) 1991-01-18 1992-01-18 Substituierte 1,2,3,4-Tetrahydrocyclopent[b]indole, 1,2,3,3a,4,8a-Hexahydrocyclopent[b]indole und verwandte Verbindungen, Zwischenprodukte und ein Verfahren zur Herstellung derselben und ihre Verwendung als Medikamente

Country Status (26)

Country Link
US (1) US5100891A (de)
EP (1) EP0496314B1 (de)
JP (1) JP2665422B2 (de)
KR (1) KR100230881B1 (de)
AT (1) ATE158790T1 (de)
AU (1) AU650315B2 (de)
BR (1) BR9200171A (de)
CA (1) CA2059610C (de)
CZ (1) CZ282732B6 (de)
DE (1) DE69222444T2 (de)
DK (1) DK0496314T3 (de)
ES (1) ES2109953T3 (de)
FI (2) FI102174B (de)
GR (1) GR3025318T3 (de)
HU (1) HUT67027A (de)
IE (1) IE920149A1 (de)
IL (1) IL100693A0 (de)
MX (1) MX9200206A (de)
NO (1) NO178397C (de)
NZ (1) NZ241305A (de)
PH (1) PH31429A (de)
PL (2) PL167465B1 (de)
RO (1) RO112505B1 (de)
RU (1) RU2077530C1 (de)
TW (1) TW198024B (de)
ZA (1) ZA92341B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5298626A (en) * 1991-01-18 1994-03-29 Hoechst-Roussel Pharmaceuticals Incorporated Select cyclopent[b]indoles
US5350762A (en) * 1993-03-08 1994-09-27 Hoechst-Roussel Pharmaceuticals Incorporated Tetrahydrocyclopent[B]indole methanamines and related compounds
ES2149742T1 (es) * 1997-07-03 2000-11-16 Asahi Chemical Ind Nuevos compuestos triciclicos que tienen anillos saturados y composiciones medicinales que contienen los mismos.
UA70334C2 (en) * 1998-10-06 2004-10-15 Janssen Pharmaceutica N V Jans BENZOTHIENO[3,2-c]PYRIDINES AS a2 ANTAGONISTS BENZOTHIENO[3,2-c]PYRIDINES AS a2 ANTAGONISTS
ID28451A (id) * 1998-10-06 2001-05-24 Janssen Pharmaceutica Nv Trisiklik piperidin-δ3 sebagai bahan farmasi
UA69420C2 (uk) * 1998-10-06 2004-09-15 Янссен Фармацевтика Н.В. ТРИЦИКЛІЧНІ <font face="Symbol">D3</font>-ПІПЕРИДИНИ ЯК <font face="Symbol">a<sub></font>2</sub>-АНТАГОНІСТИ
IT1317926B1 (it) * 2000-11-03 2003-07-15 Sigma Tau Ind Farmaceuti Derivati triciclici dell'indolo ad attivita' antiangiogenica.
AU2004247676A1 (en) 2003-06-10 2004-12-23 Smithkline Beecham Corporation Tetrahydrocarbazole derivatives and their pharmaceutical use
BRPI0411245A (pt) 2003-06-12 2006-07-18 Smithkline Beecham Corp composto, composição farmacêutica, uso de um composto, e, métodos para tratamento ou profilaxia de vìrus oncogênicos e para tratamento ou profilaxia de condições ou distúrbios devidos a infecção por hpv
EP1817025A2 (de) * 2004-11-23 2007-08-15 PTC Therapeutics, Inc. Tetrahydrocarbazole als aktivwirkstoffe zur hemmung der vegf-produktion durch translationskontrolle
GB2422828A (en) * 2005-02-03 2006-08-09 Hunter Fleming Ltd Tricyclic cytoprotective compounds comprising an indole residue
WO2013139929A1 (en) * 2012-03-22 2013-09-26 Ludwig-Maximilians-Universität München Novel means and methods for treating diseases of the central nervous system, metabolic and cardiac diseases and aging
KR20140013471A (ko) 2012-07-24 2014-02-05 주식회사 쎄코 진공증착용 발열조립체 및 이를 구비하는 진공증착장치
US10882821B1 (en) 2017-09-26 2021-01-05 The Board Of Trustees Of The Leland Stanford Junior University Enantiomeric compound for the reduction of the deleterious activity of extended nucleotide repeat containing genes

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3514462A (en) * 1966-10-21 1970-05-26 Upjohn Co 1 and 2 ethoxy 3,4,5,10 - tetrahydroazepino(3,4-b) and (2,3-b)indoles and corresponding amino derivatives thereof
US3595874A (en) * 1969-02-28 1971-07-27 Upjohn Co 3,4,5,10-tetrahydroazepino(2,3-b)indol-5a (2h)-ols
BE787537A (fr) * 1971-08-16 1973-02-14 Sterling Drug Inc Tetrahydrocarbazoles
SU482086A1 (ru) * 1973-11-30 1976-03-15 Всесоюзный Научно-Исследовательски% Химико-Фармацевтический Институт Им.С.Орджоникидзе Способ получени производных 1- -амино1,2,3,4-тетрагидрокарбазола
JPS5111760A (de) * 1974-06-18 1976-01-30 Ayerst Mckenna & Harrison
US4254134A (en) * 1978-03-17 1981-03-03 Endo Laboratories, Inc. Antidepressant 2-amino- and -2-(substituted amino)-cis-hexahydro-carbazoles

Also Published As

Publication number Publication date
IE920149A1 (en) 1992-07-29
FI20001775A (fi) 2000-08-10
ES2109953T3 (es) 1998-02-01
PL293209A1 (en) 1993-04-05
FI920192A0 (fi) 1992-01-16
RO112505B1 (ro) 1997-10-30
PL296651A1 (en) 1993-07-26
EP0496314A1 (de) 1992-07-29
NO920235L (no) 1992-07-20
FI102174B1 (fi) 1998-10-30
KR920014777A (ko) 1992-08-25
HU9200172D0 (en) 1992-04-28
DK0496314T3 (da) 1998-05-18
GR3025318T3 (en) 1998-02-27
KR100230881B1 (ko) 1999-11-15
CA2059610A1 (en) 1992-07-19
IL100693A0 (en) 1992-09-06
NO178397B (no) 1995-12-11
PL167465B1 (pl) 1995-09-30
CZ282732B6 (cs) 1997-09-17
NO178397C (no) 1996-03-20
HUT67027A (en) 1995-01-30
PL169417B1 (pl) 1996-07-31
EP0496314B1 (de) 1997-10-01
FI107919B (fi) 2001-10-31
NZ241305A (en) 1994-10-26
JPH04334367A (ja) 1992-11-20
RU2077530C1 (ru) 1997-04-20
AU1027992A (en) 1992-07-23
FI102174B (fi) 1998-10-30
CS12992A3 (en) 1992-08-12
FI920192A (fi) 1992-07-19
JP2665422B2 (ja) 1997-10-22
ZA92341B (en) 1992-09-30
TW198024B (de) 1993-01-11
BR9200171A (pt) 1992-10-06
NO920235D0 (no) 1992-01-17
ATE158790T1 (de) 1997-10-15
PH31429A (en) 1998-11-03
MX9200206A (es) 1992-08-01
DE69222444T2 (de) 1998-06-04
US5100891A (en) 1992-03-31
CA2059610C (en) 2002-04-02
AU650315B2 (en) 1994-06-16

Similar Documents

Publication Publication Date Title
DE69222444D1 (de) Substituierte 1,2,3,4-Tetrahydrocyclopent[b]indole, 1,2,3,3a,4,8a-Hexahydrocyclopent[b]indole und verwandte Verbindungen, Zwischenprodukte und ein Verfahren zur Herstellung derselben und ihre Verwendung als Medikamente
ATE211474T1 (de) Galanthamin derivate, verfahren zu ihrer herstellung und ihre verwendung als medikamente
DE69206889D1 (de) Arylalkylpiperidine-4-yl)methyl]-2-alpha-3,4,5-tetrahydro-1-(2H)-acenaphthylene-1-Onederivate, ein Verfahren für ihre Herstellung und ihre Verwendung als Medikamente
ATE140006T1 (de) 1-(pyrido(3,4-b&gt;-1,4-oxazinyl-4-yl)-1h-indole, zwischenprodukte und ein verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE3780015D1 (de) Kondensierte heterocyclische tetrahydroaminochinolinole und verwandte verbindungen, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
DE69709252D1 (de) Coumarin-Derivate, Verfahren zu deren Herstellung und deren Verwendung
DE69533214D1 (de) 2,3-Dihydro-1H-isoindolderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Hemmer der Serotoninwiederaufnahme
BR9707004A (pt) Composto processo para preparar o mesmo composição farmacêutica utilização do composto e processos para tratamento de doenças do sistema endocinológico e para a manufatura de um medicamento
ATE115133T1 (de) (1,2,3,4-tetrahydro-9-acridinimino)cyclohexan- carbonsäure und verwandte verbindungen, ein verfahren zu ihrer herstellung und ihre verwendung als medikamente.
DK0758336T3 (da) Fremgangsmåde til fremstilling af 1-(3-trialkylsilylphenyl)-2,2,2-trifluorethanonderivater
DE59205480D1 (de) Verfahren zur Herstellung von 4-Hydroxymethyl-tetrahydropyranen
ATE247641T1 (de) Pyridin-zwischenprodukte, verwendbar zur herstellung von beta-adrenergischen rezeptor- agonisten
DE69629112D1 (de) Verfahren zur synthese von phosphororganischen verbindungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition